Takeda Pharmaceutical Company Limited (TAK)
17.22 0.00 (0.00%)
Pre-market: 4:48AM EST
- Business Wire
BioLife Plasma Services Announces Expansion of Plasma Donation Centers Into California
BioLife Plasma Services announces expansion of plasma donation centers into California.
- Business Wire
Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced today that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-019) in Japan. Earlier this month, Takeda completed enrollment in the company’s Phase 1/2 immunogenicity and safety study of Moderna’s COVID-19 vaccine candidate (TAK-919) in Japan.
- Business Wire
Takeda Receives Prestigious EURORDIS 2021 Black Pearl Award for Patient Engagement
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") Takeda has been announced the winner of the EURORDIS 2021 Award for Patient Engagement in recognition of the company’s unwavering commitment to rare disease patients and its comprehensive partnerships with the rare disease patient community.
